Independent Pharmacists Raise Concerns Over GKV Savings Law Hearing
The association representing independent pharmacists has voiced its dissatisfaction regarding the recent public hearing on the statutory health insurance contribution stabilization law (GKV-Spargesetz). During this session, a total of 90 associations and experts were invited to share their perspectives on the proposed legislation, which is scheduled for approval before the parliamentary summer recess.
Despite the apparent inclusivity of the hearing, the independent pharmacists' association argued that the process lacked genuine participatory value. According to their analysis, each participant was allocated less than 90 seconds to present their input, which, in their view, does not allow for meaningful discussion or thorough debate. The association interpreted this approach as bureaucratic rather than democratic, stating that the format amounted to superficial involvement rather than substantive engagement.
The association further expressed concern about its exclusion from the list of invited pharmacy organizations. While the Federal Union of German Associations of Pharmacists (ABDA) was present at the hearing, no other pharmacist associations were included. The independent pharmacists' association, representing approximately 1,700 pharmacists, questioned the criteria used to determine which organizations were given a platform, highlighting a perceived lack of transparency in the parliamentary selection process. They suggested that the invitation system may systematically restrict the diversity of perspectives included in the debate.
The association also criticized what they see as a broader trend of political disengagement with the pharmacy sector. They suggested that the legislative process surrounding the GKV-Spargesetz is being expedited without sufficient input from key stakeholders in pharmaceutical care. According to the association's leadership, this approach may undermine the long-term sustainability and accessibility of medication supply across the country.
Such exclusion is not without precedent. In a previous hearing concerning the Pharmacy Supply Development Act (ApoVWG), the independent pharmacists' association was similarly omitted from the list of 40 participating organizations. Although the association's chair was invited as an individual expert, she declined the invitation due to concerns about the political context of her participation. The association noted that, ahead of the ApoVWG hearing, important topics had been coordinated among various pharmacy organizations, potentially mitigating the impact of their absence. Nonetheless, they continue to express concern about recurring patterns of limited representation in legislative consultation processes.
The structure of pharmacy representation at public hearings typically prioritizes major umbrella organizations such as ABDA, which is considered the official representative body for the majority of German pharmacists through its constituent chambers. However, independent pharmacy associations argue that this model does not fully capture the diversity of professional perspectives within the sector.
Discussions within the sector have also addressed other ongoing legal and regulatory issues, such as reimbursement models and adjustments to fixed remuneration rates. During the recent hearing, a representative from the Federal Ministry of Health indicated that planned changes to remuneration would be implemented concurrently with increased discounts for health insurance providers, reflecting ongoing adjustments within the framework of the new savings law.
The independent pharmacists' association maintains that a more inclusive consultation process would enrich policy development and ensure that the needs of pharmacists and patients across the country are adequately addressed. The association continues to advocate for greater transparency and broader stakeholder participation in future legislative processes affecting the pharmacy sector.